First medtech firm audited under MDSAP urges companies to pay closer attention to international rules
This article was originally published in SRA
The first medical device manufacturer to experience a facility audit under the international medical device single audit program (MDSAP) had an eye-opening moment when it was cited for not keeping a sharper eye on Australian regulatory requirements.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.